Cibus (CBUS) Interest Expenses (2016 - 2026)
Cibus (CBUS) posted Interest Expenses of $1.3 million for Q4 2025, down 97.28% sequentially from $46.7 million in Q3 2025, and up 159.84% YoY from $488000.0 in Q4 2024.
Cibus (CBUS) Interest Expenses (2016 - 2026) Analysis & Trends
Cibus has reported Interest Expenses for 10 years, with the latest figure at $1.3 million in Q4 2025.
- Quarterly Interest Expenses rose 159.84% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.9 million (up 32.18% YoY) and the FY2025 annual result came in at $182.1 million, up 75.54% from the prior year.
- Interest Expenses eased to $1.3 million in Q4 2025 per CBUS's latest filing, from $46.7 million in the prior quarter.
- Over five years, Interest Expenses peaked at $53.3 million in Q2 2024 and troughed at $68000.0 in Q2 2022.
- A 5-year average of $9.0 million and a median of $878000.0 in 2024 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses plunged 95.13% in 2023, then jumped 20641.56% in 2024.
- Over 5 years, Interest Expenses stood at $356000.0 in 2021, then tumbled by 80.06% to $71000.0 in 2022, then soared by 4238.03% to $3.1 million in 2023, then sank by 84.16% to $488000.0 in 2024, then jumped by 159.84% to $1.3 million in 2025.
- According to Business Quant data, Interest Expenses over the past three periods registered $1.3 million, $46.7 million, and $22.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 82.05 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 20.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 93.62 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -4.89 Mn |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.75 Mn |
| Jun 30, 2026 | 43.75 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 46.66 Mn |
| Sep 30, 2025 | 46.66 Mn |
| Jun 30, 2025 | 22.58 Mn |
| Jun 30, 2025 | 22.58 Mn |
| Mar 31, 2025 | 22.58 Mn |
| Mar 31, 2025 | 22.58 Mn |
| Dec 31, 2024 | 488,000.00 |
| Dec 31, 2024 | 488,000.00 |
| Sep 30, 2024 | 15.97 Mn |
| Sep 30, 2024 | 15.97 Mn |
| Jun 30, 2024 | 53.32 Mn |
| Jun 30, 2024 | 53.32 Mn |
| Mar 31, 2024 | 9.79 Mn |
| Mar 31, 2024 | 9.79 Mn |
| Dec 31, 2023 | 3.08 Mn |
| Dec 31, 2023 | 3.08 Mn |